Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-28 @ 6:31 PM
Study NCT ID:
NCT00106834
Status:
COMPLETED
Last Update Posted:
2011-05-19
First Post:
2005-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis
Sponsor:
Centocor, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR003130
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None